Study in Children Who Have Switched to Isosource Junior Mix Formula

Nestlé

Status

Completed

Conditions

Cerebral Palsy

Treatments

Dietary Supplement: Isosource Junior Mix

Study type

Observational

Funder types

Other

Industry

Identifiers

NCT05020756

Blend 002

Details and patient eligibility

About

A Retrospective study In Children who have switched to Isosource Junior Mix formula (RICIMIX study) will review paediatric children > 12 months of age who require Isosource Junior Mix as an enteral tube feeding formula and have consumed the formula for at least 1 month. The purpose of this study is to understand If there has been an improvement in outcomes/ experiences

The current usage of ISJMIX formula in children who require blended diets
Improved feeding intolerances
Improved patient outcomes/ experiences

Full description

Retrospective data will be collected using questionnaire by the dietitians at the nutrition and dietetic department. All completed questionnaires will be sent back to Nestle Health Science/ CRO company.

The primary objectives:

The following measures will be collected retrospectively after 1 month use of ISJMIX

Feeding tolerance [no change, tolerance improved, tolerance worsened]: gastric residuals, gagging/retching, vomiting, abdominal distention/ gas, stool consistency issues (too hard, too loose)
Volume of formula consumed in a day

The secondary objective is to collect restropective data on:

Any improved patient outcomes noted
Calculate the potential cost savings made when using ISJMIX to help manage the feeding intolerances
Calculate the potential costs benefit of using ISJMIX over other standard formulas

Enrollment

43 patients

Sex

All

Ages

12 months to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria